Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Donsmark M et al. – The mean injection force required to operate NovoPen 4 was reduced up to 50% compared with NovoPen 3 (P<0.001), and the mean dosage display for NovoPen 4 was over four times larger than for NovoPen 3 (P<0.001). Based on these findings, patients with diabetes who have manual or visual impairment should find it easier to dose insulin with NovoPen 4.

Today in Diabetes...keeping you current

Resistance training for obese, type 2 diabetic adults: a review of the evidence
Obesity Reviews, 12/15/09

The DAFNE Collaborative. Experiences of developing a nationally delivered evidence-based, quality-assured programme for people with type 1 diabetes
Practical Diabetes International, 12/15/09

Efficacy of insulin lispro in pregnancies complicated with pregestational diabetes mellitus
Practical Diabetes International, 12/15/09

Today in Pharmacology/kinetics...keeping you current

The role of flow-mediated dilatation in the evaluation and development of antiatherosclerotic drugs
Current Opinion in Lipidology, 12/15/09

Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/15/09

Effect of Obesity on Platelet Reactivity and Response to Low-Dose Aspirin
Preventive Cardiology, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address